Variant report
Variant | nsv1021013 |
---|---|
Chromosome Location | chr9:17045105-17072402 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:319)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:17063303..17064146-chr9:17462547..17463504,3 | MCF-7 | breast: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CNTLN-1 | chr9:17048917-17049039 | ENSG00000237153.1 |
2 | lnc-CNTLN-4 | chr9:17053899-17054200 | NONHSAT130298 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RN7SL720P | TF binding region |
ENSG00000237153 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs416529 | chr9:17045105-17045106 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs540170346 | chr9:17045155-17045156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs187809651 | chr9:17045217-17045218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs536987860 | chr9:17045226-17045227 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs148282758 | chr9:17045275-17045276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs568911329 | chr9:17045288-17045289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs141256235 | chr9:17045320-17045321 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs562046278 | chr9:17045334-17045335 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs574124905 | chr9:17045342-17045343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs544291078 | chr9:17045343-17045344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373802398 | chr9:17045370-17045371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs373443744 | chr9:17045371-17045372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs375061302 | chr9:17045374-17045375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562580706 | chr9:17045391-17045392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs150778458 | chr9:17045392-17045393 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545717094 | chr9:17045396-17045397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564373402 | chr9:17045472-17045473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs192586307 | chr9:17045480-17045481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577196555 | chr9:17045511-17045512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs117422595 | chr9:17045540-17045541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546725171 | chr9:17045556-17045557 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568156425 | chr9:17045596-17045597 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570793480 | chr9:17048947-17048948 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs380045 | chr9:17048960-17048961 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs534732370 | chr9:17048972-17048973 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs548716808 | chr9:17048975-17048976 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs552273134 | chr9:17048984-17048985 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs10962832 | chr9:17048990-17048991 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs530932263 | chr9:17048998-17048999 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs568579552 | chr9:17049001-17049002 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs552652266 | chr9:17049017-17049018 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs138621332 | chr9:17049026-17049027 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs558592545 | chr9:17049800-17049801 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs540673247 | chr9:17049828-17049829 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs558981478 | chr9:17049830-17049831 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs189252761 | chr9:17049923-17049924 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs541775842 | chr9:17049931-17049932 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs149856565 | chr9:17049937-17049938 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs188940880 | chr9:17051035-17051036 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs192282562 | chr9:17051041-17051042 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs557693838 | chr9:17051049-17051050 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs112114939 | chr9:17051099-17051100 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs381680 | chr9:17051103-17051104 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs558370727 | chr9:17051123-17051124 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs77916824 | chr9:17051135-17051136 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs540743331 | chr9:17051145-17051146 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs416421 | chr9:17051170-17051171 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs180784778 | chr9:17051270-17051271 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs111744960 | chr9:17051273-17051274 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs572062224 | chr9:17051274-17051275 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Breast cancer | 21364760 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:17044800-17045600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr9:17052800-17053200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr9:17053200-17062600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr9:17057400-17058400 | Enhancers | Fetal Intestine Large | intestine |
5 | chr9:17057600-17058200 | Enhancers | Duodenum Mucosa | Duodenum |
6 | chr9:17057600-17058200 | Enhancers | Fetal Intestine Small | intestine |
7 | chr9:17057600-17058200 | Enhancers | HepG2 | liver |
8 | chr9:17058000-17058400 | Enhancers | Stomach Mucosa | stomach |
9 | chr9:17058400-17062200 | Weak transcription | Fetal Intestine Large | intestine |
10 | chr9:17059800-17060400 | Enhancers | Adipose Nuclei | Adipose |
11 | chr9:17060200-17061000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr9:17062200-17062800 | Enhancers | Fetal Intestine Small | intestine |
13 | chr9:17062200-17063200 | Enhancers | Fetal Intestine Large | intestine |
14 | chr9:17062600-17062800 | ZNF genes & repeats | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr9:17064400-17065200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
16 | chr9:17064600-17064800 | Enhancers | A549 | lung |
17 | chr9:17064600-17066200 | Enhancers | HUVEC | blood vessel |
18 | chr9:17064800-17065000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr9:17064800-17065400 | Enhancers | Liver | Liver |
20 | chr9:17065000-17065400 | Enhancers | Osteobl | bone |
21 | chr9:17065000-17078200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr9:17065200-17065400 | Enhancers | Fetal Intestine Large | intestine |
23 | chr9:17068600-17069000 | Enhancers | HUES64 Cell Line | embryonic stem cell |